Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, October 21, 2022
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
[ Fri, Oct 21st 2022
] - WOPRAI
Corinne Jenkins Maintained (SWTX) at Strong Buy with Decreased Target to $44 on, Oct 21st, 2022
Corinne Jenkins of Goldman Sachs, Maintained "SpringWorks Therapeutics, Inc." (SWTX) at Strong Buy with Decreased Target from $51 to $44 on, Oct 21st, 2022.
Corinne has made no other calls on SWTX in the last 4 months.
There is 1 other peer that has a rating on SWTX. Out of the 1 peers that are also analyzing SWTX, 0 agree with Corinne's Rating of Hold.
This is the rating of the analyst that currently disagrees with Corinne
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $103 on, Monday, September 12th, 2022
